secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001193125-26-133247
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics to be delisted from Nasdaq on April 1 after winding-up petition
--------------------------------------------------------------------------------

- Nasdaq will suspend ITRM shares at open on April 1, 2026; Form 25-NSE to follow.
- Company withdrew its appeal of the prior delisting determination after filing winding-up petition on March 27, 2026.
- Joint provisional liquidators Damien Murran and Jennifer McMahon (Teneo) appointed; company in provisional liquidation.
- Iterum will not file Form 10-K for FY 2025 or any future SEC reports due to limited cash resources and winding-up process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526133247/0001193125-26-133247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526133247/itrm-20260330.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-133247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer